Profiles

Keywords
Last Name
Institution

Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma.

Chamberlain FE, Wilding C, Jones RL, Huang P. Pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. Expert Opin Investig Drugs. 2019 Jun; 28(6):505-511.

View in: PubMed

collapse authors with profiles